Nature:微生物群落的平衡性决定自身免疫疾病是否发生

2012-04-14 T.Shen 生物谷

银屑病,特定的真菌可以激活和一定免疫疾病有关系的免疫细胞的功能,而另外一些微生物,尤其是存在于人类皮肤上的细菌,可以起到抗炎症的作用。(Credit: © quayside / Fotolia) Copyright ©版权归生物谷所有,若未得到Bioon授权,请勿转载。 当对机体有益的微生物正常工作的时候,和自身免疫疾病如银屑病等相关免疫细胞便会主动起到抗炎症的功效,近日,

银屑病,特定的真菌可以激活和一定免疫疾病有关系的免疫细胞的功能,而另外一些微生物,尤其是存在于人类皮肤上的细菌,可以起到抗炎症的作用。(Credit: © quayside / Fotolia)

Copyright ©版权归生物谷所有,若未得到Bioon授权,请勿转载。

当对机体有益的微生物正常工作的时候,和自身免疫疾病如银屑病等相关免疫细胞便会主动起到抗炎症的功效,近日,来自瑞士的科学家通过研究发现,特定的真菌可以激活和一定免疫疾病有关系的免疫细胞的功能,而另外一些微生物,尤其是存在于人类皮肤上的细菌,可以起到抗炎症的作用。

研究者Christina Zielinski表示,混合的微生物群在慢性疾病的发展过程中起到了一种决定性的作用,而且引起疾病的关键细胞也可以发展成为抗炎细胞。相关的研究成果刊登在了近日的国际杂志Nature上。研究者识别出了和致病的或者抗炎性免疫细胞相关的基本信号分子,这种信号分子在白细胞介素1β中被发现。信号分子存在的时候,自身免疫的免疫细胞会发生功能性的破坏以及释放相应的炎性信使物质;如果信号分子缺失,免疫细胞将会成熟变成抗炎性相似物。更有意思的是,这还是我们机体的微生物决定白细胞介素1β是否产生并且可以决定模式的选择。

目前所发现的显现可以促使研究者去寻找患有过度产生白细胞介素1β的病人,这些病人是自体免疫系统并发症的患者,尤其是孩子,经常遭受多重的症状,比如发烧、关节炎和皮疹等。这些病症的发展无人能够解释。研究者们检测了抗体封堵白细胞介素1β的方法是否能够在免疫细胞中产生抗炎潜力,事实上,引入这种治疗方法后,免疫细胞可以产生炎症延迟信使分子,并且产生记忆,在长时间内释放信使分子物质。

研究者Christina Zielinski表示,我们确定,微生物群落的不平衡性对于诸如风湿、银屑病等慢性炎性疾病有一种决定性的影响。我们有机体携带的细菌是人体机体细胞的10倍以上,如何维持其平衡性并不容易,白细胞介素1β如今被证明是一个决定性的分析开关,微生物可以用此开关来指挥机体是健康状态还是发病状态。研究者认为通过阻断分子物质来治疗炎性疾病未来将非常有潜力,相比其它免疫治疗方法来说,这种免疫治疗方法可以促使细胞转变成抗炎细胞,而不是失去抵御疾病的能力。(生物谷:T.Shen编译)

Copyright ©版权归生物谷所有,若未得到Bioon授权,请勿转载。

doi:10.1038/nature10957
PMC:
PMID:

Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β

Christina E. Zielinski,1 Federico Mele,1 Dominik Aschenbrenner,1 David Jarrossay,1 Francesca Ronchi,1 Marco Gattorno,2 Silvia Monticelli,1 Antonio Lanzavecchia1, 3 & Federica Sallusto1

IL-17-producing CD4+ T helper cells (TH17) have been extensively investigated in mouse models of autoimmunity1. However, the requirements for differentiation and the properties of pathogen-induced human TH17 cells remain poorly defined. Using an approach that combines the in vitro priming of naive T cells with the ex vivo analysis of memory T cells, we describe here two types of human TH17 cells with distinct effector function and differentiation requirements. Candida albicans-specific TH17 cells produced IL-17 and IFN-γ, but no IL-10, whereas Staphylococcus aureus-specific TH17 cells produced IL-17 and could produce IL-10 upon restimulation. IL-6, IL-23 and IL-1β contributed to TH17 differentiation induced by both pathogens, but IL-1β was essential in C. albicans-induced TH17 differentiation to counteract the inhibitory activity of IL-12 and to prime IL-17/IFN-γ double-producing cells. In addition, IL-1β inhibited IL-10 production in differentiating and in memory TH17 cells, whereas blockade of IL-1β in vivo led to increased IL-10 production by memory TH17 cells. We also show that, after restimulation, TH17 cells transiently downregulated IL-17 production through a mechanism that involved IL-2-induced activation of STAT5 and decreased expression of ROR-γt. Taken together these findings demonstrate that by eliciting different cytokines C. albicans and S. aureus prime TH17 cells that produce either IFN-γ or IL-10, and identify IL-1β and IL-2 as pro- and anti-inflammatory regulators of TH17 cells both at priming and in the effector phase.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1879195, encodeId=930318e919549, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Sep 24 05:33:00 CST 2012, time=2012-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824543, encodeId=e365182454352, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sun Sep 02 10:33:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810772, encodeId=49fa1810e72e5, content=<a href='/topic/show?id=f51a8635118' target=_blank style='color:#2F92EE;'>#自身免疫疾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86351, encryptionId=f51a8635118, topicName=自身免疫疾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Fri Nov 23 05:33:00 CST 2012, time=2012-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367713, encodeId=4827136e713d8, content=<a href='/topic/show?id=2cee50e22c6' target=_blank style='color:#2F92EE;'>#微生物群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50722, encryptionId=2cee50e22c6, topicName=微生物群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511207, encodeId=b2c1151120ee5, content=<a href='/topic/show?id=3f922910088' target=_blank style='color:#2F92EE;'>#免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29100, encryptionId=3f922910088, topicName=免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a3610309283, createdName=晓辰, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587065, encodeId=5bb2158e065c3, content=<a href='/topic/show?id=6c1786352c6' target=_blank style='color:#2F92EE;'>#自身免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86352, encryptionId=6c1786352c6, topicName=自身免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0d17427282, createdName=gao_jian4223, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
    2012-09-24 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1879195, encodeId=930318e919549, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Sep 24 05:33:00 CST 2012, time=2012-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824543, encodeId=e365182454352, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sun Sep 02 10:33:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810772, encodeId=49fa1810e72e5, content=<a href='/topic/show?id=f51a8635118' target=_blank style='color:#2F92EE;'>#自身免疫疾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86351, encryptionId=f51a8635118, topicName=自身免疫疾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Fri Nov 23 05:33:00 CST 2012, time=2012-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367713, encodeId=4827136e713d8, content=<a href='/topic/show?id=2cee50e22c6' target=_blank style='color:#2F92EE;'>#微生物群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50722, encryptionId=2cee50e22c6, topicName=微生物群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511207, encodeId=b2c1151120ee5, content=<a href='/topic/show?id=3f922910088' target=_blank style='color:#2F92EE;'>#免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29100, encryptionId=3f922910088, topicName=免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a3610309283, createdName=晓辰, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587065, encodeId=5bb2158e065c3, content=<a href='/topic/show?id=6c1786352c6' target=_blank style='color:#2F92EE;'>#自身免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86352, encryptionId=6c1786352c6, topicName=自身免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0d17427282, createdName=gao_jian4223, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1879195, encodeId=930318e919549, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Sep 24 05:33:00 CST 2012, time=2012-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824543, encodeId=e365182454352, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sun Sep 02 10:33:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810772, encodeId=49fa1810e72e5, content=<a href='/topic/show?id=f51a8635118' target=_blank style='color:#2F92EE;'>#自身免疫疾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86351, encryptionId=f51a8635118, topicName=自身免疫疾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Fri Nov 23 05:33:00 CST 2012, time=2012-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367713, encodeId=4827136e713d8, content=<a href='/topic/show?id=2cee50e22c6' target=_blank style='color:#2F92EE;'>#微生物群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50722, encryptionId=2cee50e22c6, topicName=微生物群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511207, encodeId=b2c1151120ee5, content=<a href='/topic/show?id=3f922910088' target=_blank style='color:#2F92EE;'>#免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29100, encryptionId=3f922910088, topicName=免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a3610309283, createdName=晓辰, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587065, encodeId=5bb2158e065c3, content=<a href='/topic/show?id=6c1786352c6' target=_blank style='color:#2F92EE;'>#自身免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86352, encryptionId=6c1786352c6, topicName=自身免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0d17427282, createdName=gao_jian4223, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1879195, encodeId=930318e919549, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Sep 24 05:33:00 CST 2012, time=2012-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824543, encodeId=e365182454352, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sun Sep 02 10:33:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810772, encodeId=49fa1810e72e5, content=<a href='/topic/show?id=f51a8635118' target=_blank style='color:#2F92EE;'>#自身免疫疾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86351, encryptionId=f51a8635118, topicName=自身免疫疾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Fri Nov 23 05:33:00 CST 2012, time=2012-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367713, encodeId=4827136e713d8, content=<a href='/topic/show?id=2cee50e22c6' target=_blank style='color:#2F92EE;'>#微生物群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50722, encryptionId=2cee50e22c6, topicName=微生物群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511207, encodeId=b2c1151120ee5, content=<a href='/topic/show?id=3f922910088' target=_blank style='color:#2F92EE;'>#免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29100, encryptionId=3f922910088, topicName=免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a3610309283, createdName=晓辰, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587065, encodeId=5bb2158e065c3, content=<a href='/topic/show?id=6c1786352c6' target=_blank style='color:#2F92EE;'>#自身免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86352, encryptionId=6c1786352c6, topicName=自身免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0d17427282, createdName=gao_jian4223, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1879195, encodeId=930318e919549, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Sep 24 05:33:00 CST 2012, time=2012-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824543, encodeId=e365182454352, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sun Sep 02 10:33:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810772, encodeId=49fa1810e72e5, content=<a href='/topic/show?id=f51a8635118' target=_blank style='color:#2F92EE;'>#自身免疫疾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86351, encryptionId=f51a8635118, topicName=自身免疫疾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Fri Nov 23 05:33:00 CST 2012, time=2012-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367713, encodeId=4827136e713d8, content=<a href='/topic/show?id=2cee50e22c6' target=_blank style='color:#2F92EE;'>#微生物群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50722, encryptionId=2cee50e22c6, topicName=微生物群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511207, encodeId=b2c1151120ee5, content=<a href='/topic/show?id=3f922910088' target=_blank style='color:#2F92EE;'>#免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29100, encryptionId=3f922910088, topicName=免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a3610309283, createdName=晓辰, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587065, encodeId=5bb2158e065c3, content=<a href='/topic/show?id=6c1786352c6' target=_blank style='color:#2F92EE;'>#自身免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86352, encryptionId=6c1786352c6, topicName=自身免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0d17427282, createdName=gao_jian4223, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1879195, encodeId=930318e919549, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Sep 24 05:33:00 CST 2012, time=2012-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824543, encodeId=e365182454352, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Sun Sep 02 10:33:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810772, encodeId=49fa1810e72e5, content=<a href='/topic/show?id=f51a8635118' target=_blank style='color:#2F92EE;'>#自身免疫疾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86351, encryptionId=f51a8635118, topicName=自身免疫疾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Fri Nov 23 05:33:00 CST 2012, time=2012-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1367713, encodeId=4827136e713d8, content=<a href='/topic/show?id=2cee50e22c6' target=_blank style='color:#2F92EE;'>#微生物群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50722, encryptionId=2cee50e22c6, topicName=微生物群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511207, encodeId=b2c1151120ee5, content=<a href='/topic/show?id=3f922910088' target=_blank style='color:#2F92EE;'>#免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29100, encryptionId=3f922910088, topicName=免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a3610309283, createdName=晓辰, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587065, encodeId=5bb2158e065c3, content=<a href='/topic/show?id=6c1786352c6' target=_blank style='color:#2F92EE;'>#自身免疫疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86352, encryptionId=6c1786352c6, topicName=自身免疫疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0d17427282, createdName=gao_jian4223, createdTime=Sun Apr 15 15:33:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]

相关资讯

Immunity:发现巨噬细胞识别危险细菌的蛋白“侦察兵”

上百万个“好”细菌和谐地存在于健康人肠道内和皮肤上。当有害的细菌攻击时,免疫系统作出反击:派送白细胞去摧毁导致疾病的侵入者。但是白细胞如何辨别哪些细菌是好的以及哪些是坏的呢? 美国西北大学芬伯格医学院(Northwestern University Feinberg School of Medicine)风湿病学研究教授Christian Stehlik领导的研究小组研究了一种白细胞类型---巨

Immunity:首次揭示树突细胞识别外源物机制有望开发下一代疫苗

预测性的人CLEC9A二维结构(S:半胱氨酸残基;Y:酪氨酸残基),图片来自Cristal Huysamen et al. CLEC9A Is a Novel Activation C-type Lectin-like Receptor Expressed on BDCA3+ Dendritic Cells and a Subset of Monocytes. June 13, 2008 The

Nat. Med.:开发出利用基因枪传送DNA新技术拯救免疫系统

胸腺内单分子标记阳性T细胞发育图,图片来自维基共享资源。 根据2012年2月26日发表在《自然-医学》期刊上的一篇研究论文,来自美国罗耀拉大学的研究人员报道了一种大有希望的新技术:它能潜在地将免疫系统杀伤性T细胞(killer T cell)变成更加强有力的对抗感染和可能对抗癌症的武器。 这种技术涉及传送DNA到免疫系统的抗原呈递细胞(antigen-presenting cell)。DNA指

Nat. Comm.:帅气男性吸引女性原因——免疫力更强

近日,根据英国阿伯泰大学进行的一项新研究,男性英俊的面容和完美的体形是他们拥有更多抗体的一种标志,而更多抗体自然意味着更为强大的免疫系统。相关论文发表在Nature Communications上。 阿伯泰大学进行的研究发现,女性本能地希望与帅气的男人结合,将更健康的基因遗传给下一代。研究指出,睾丸激素水平较高的男性可能对女人更具有吸引力,原因就在于他们拥有更强的免疫系统。男性的面部特征取决于睾

Science:揭示治疗传染病的新策略---抵抗感染

病原体能够直接对宿主组织造成伤害。宿主免疫系统通过耐受机制降低宿主中病原体数量。免疫反应也能够对宿主组织造成伤害。宿主能够通过降低病原体和免疫病理反应造成的直接伤害的耐受机制来降低成本。图片来自Science/AAAS。 免疫系统通过检测和消除入侵病原体而保护机体免受感染。这两种策略构成常规临床方法对抗传染性疾病的的基础。来自葡萄牙古尔班基安科学研究所(Instituto Gulbenkian

J. Immunol.:人自然杀伤细胞在异种移植排斥中起重要作用

细胞毒性T细胞和自然杀伤细胞互补性作用的示意图,图片来自维基共享资源。 来自西班牙Bellvitge生物医学研究所(Bellvitge Biomedical Research Institute)的研究人员首次研究人自然杀伤细胞(natural killer cell, NK)抗猪软骨细胞的反应。研究结果于2012年1月27日发表在Journal of Immunology期刊上,表明作为天然免